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1. Introduction 
Several investigations, as reviewed by Anderson [ 1] 
and Billingham [2], were inspired by the fact that the 
foetus, though possessing different genetic features, is 
not rejected by the maternal organism like an allograft. 
Indeed it could be shown, that the maternal organism 
may specifically be sensitized against placental antigens 
mediated by the cellular immunity system [3]. An 
altered reactivity of this system might be one reason, 
why a rejection does not occur [4,5]. This idea is 
supported by the observation that the lymphocytes of 
pregnant women have a diminished non-specific 
reactivity, as measured by the phytohemagglutinin 
(PHA) stimulation test [6,7] . One possible explana- 
tion for this phenomenon was proposed by different 
reports. They dealt with an inhibitory effect of human 
chorionic gonadotropin (hCG) [8-lo] and human 
chorionic somatomammotropin (hCS) [9] , respectively, 
on the response of lymphocytes to PHA. These observa- 
tions might explain the mechanism of acception of the 
foetus by the maternal organism in connection with 
the high formation rate of hCG (up to 1 X 106IU/day) 
during the first trimester of pregnancy. The investiga- 
tions reported in the literature [9,10] were performed 
with crude hCG preparations. Therefore, we have 
studied the effect of highly purified hCG as well as of 
fractions obtained in the course of hCG purification 
on lymphocyte stimulation. 
2. Methods and materials 
Crude hCG (4300 IU/mg) was purchased from 
Schering AG, Berlin, GFR. Highly purified hCG with 
North-Holland Publishing Company - Amsterdam 
a biological activity of 13 000 IU/mg was prepared 
according to Canfleld et al. [l l] with slight 
modifications [ 121. The purification was achieved by 
a batch absorption of the crude hormone on SP- 
Sephadex CSO followed by chromatography on 
DEAE-Sephadex A50 and by a final chromatography 
on Sephadex G 150. Biological activity was assayed by 
the rat prostate test [ 121. 
Lymphocyte cultures: Freshly drawn heparinized 
human blood was allowed to sediment at 37°C for 
about 2 hr. The supernatant leukocyte-containing 
plasma was collected and passed through a column 
packed with nylon fibres (Leuko-Pak@, Fenwal Lab., 
Morton Grove, 111.) at 37°C. Cells were centrifuged 
at 160 g for 10 mm and washed once with culture 
medium (Eagles MEM with 10 mM HEPES-buffer, 
pH 7.4,200 IU/ml Penicillin, 200 I.tg/ml Streptomycin 
and 10% inactivated autologous serum). Lymphocyte 
cultures were prepared in test tubes (Falcon Plastics 
No. 2006, Los Angeles, Calif.), each tube containing 
1 million mononucleated cells in 1 ml culture.medium. 
The lymphocytes were preincubated 24 hr in the 
presence of the protein fraction to be tested for 
inhibition. Thereafter, PHA stimulation was started by 
adding 10 111 PHA-M (Difco Labs., Detroit, Michigan). 
46 hr later, 2 hr before the end of incubation, 
0.5 E.tCi of [3H] thymidine (spec. act. 2 Ci/mmol, 
The Radiochemical Centre, Amersham) were added to 
each culture. Cells were collected on membrane filters 
(Millipore, PHWP 02500), washed with 5 ml saline, 
3 X 5 ml 5% TCA and 5 ml 0.1 N HCl. The incorpor- 
ated radioactivity was measured in a liquid scintillation 
spectrometer (Packard Instruments). The uninhibited 
PHA stimulation of lymphocytes, determined as 
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incorporation of [3H] thymidine, in the mean yielded 
35 000 cpm per culture. Cultures which were incubated 
in the absence of PHA displayed a blank value of 
330 cpm per culture. In the case of purified hCG some 
assays were performed at one fifth the scale. Cell 
viability was tested by Trypan Blue exclusion before 
the addition of the labelled thymidine. 
Anti-hCG antiserum was obtained from goats using 
highly purified hCG (13 000 IU/mg) for immunization 
as described elsewhere [ 131. 
Anti-hCG-fl subunit antiserum was obtained from 
rabbits using a p subunit preparation prepared as 
described by Mere et al. [ 121. Per animal 250 pg of 
/3 subunit dissolved in complete Freund adjuvant and 
saline, respectively, were applicated three times, at 
intervals of one month. 
3. Results 
The influence of hCG fractions of different purity 
and biological activity on the PHA-dependent 
transformation of lympocytes was investigated. Unlike 
the commercially available crude hormone (see fig.la) 
highly purified hCG (13 000 IU/mg) is not able to 
inhibit this reaction up to a dose of 13 000 IU/ml. 
This result is not confined to a certain batch of highly 
purified hormone. With one exception, the inhibitory 
pmfied hCG 
crude hCG 
properties of the fractions which are separated from 
hCG during the different purification steps do not 
exceed the inhibition caused by the crude hormone. 
The fraction which is separated in the first step of 
hCG purification, however, has a higher inhibitory 
potency. This purification step consists in a batch 
adsorption of crude hCG on SP-Sephadex. About half 
of the crude hormone is not adsorbed. This material 
(fraction I) has no detectable biological activity in the 
rat prostate assay for hCG [ 121 whereas the adsorbed 
material (fraction II) which is used for further 
purification is biologically active (6000 IU/mg). A 
comparison of the inhibition properties between highly 
purified hCG, crude hCG and fraction I is presented 
in fig.lb and in table 1, respectively. Even at the 
highest concentrations of the investigated substances 
cell viability is not diminished. In contrast to the 
stimulated cultures the inhibited ones show almost no 
agglutination of the cells. 
4. Discussion 
The results presented in this paper clearly indicate 
that the ability to inhibit the PHA induced transforma- 
tion of lymphocytes is not correlated with the enrich- 
ment of the biological activity during the purification 
of hCG. To the contrary, this property is lost during 
the purification procedure. This may by the conse- 
Fig.1. Influence of purified hCG, crude hCG and fraction I on the PHA-induced [3H] thymidine incorporation into human peripherdl 
lymphocytes. The result of one representative assay is shown. In tig.la purified hCG is compared with crude hCG on the basis of 
hormonal activity. Fig.lb compares fraction I, crude hCG and purified hCG on the basis of weight. The mean values of triplicate 
assays are expressed as percent of the PHA-stimulated control cultures. The vertical bars represent the range. 
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Table 1 
PHA stimulation of lymphocytes in presence of highly purified hCG, crude hCG and 
fraction I at a concentration of 1 mg/ml and 4300 IU/ml; respectively. 
Highly purified Crude hCG Fraction I 
hCG, 4300 IU/ml 4300 IU/ml = I mg/mi 1 mg/ml 
Number of experiments 11 9 5 
PHA-stimulation in % 
of uninhibited control 
cultures 
95.3 + 20.1% 44.8 * 18.8% 20.5 t: 12.4% 
The difference between the results for highly puritied hCG and crude hCG is significant 
(p<O.OOl), as well as the difference between crude hormone and fraction 1 tp<O.O25) as 
determined with the Mann-Whitney test [ 211. 
The PHA stimulated control cultures yielded in the mean 35 000 cpm, the blank values 
displayed 330 cpm. 
quence of the loss of a definite biological property of 
the hormone which possibly cannot be determined by 
means of the stimuIato~ effect on the gonades. On 
the other hand a substance distinct from hCG possessing 
this inhibitory ability might be separated during the 
purification. The above results favour the latter 
possib~ity because the inhibitor property is enriched 
in a fraction which shows no hCG activity. The idea 
that this substance might consist of either desialylated 
hormone or the isolated fl subunit seems to be unlikely 
for the following reasons: First, fraction I reacts very 
weakly with an antiserum against hCG, contrary to 
desialylated hCG which shows a very good reaction. 
Furthermore, desialylated hCG should not be a part of 
fraction I because of its isoelectric point of pH 9.5. 
Secondly, no reaction could be observed between 
fraction I and an antiserum which is merely specific 
for the isolated fl subunit of hCG. 
A possible relation of the inhibiting substance to 
various pregnancy-correlated factors [4,15-17,191 
which show an influence in different tests for cell 
mediated immunity has to be considered. Furthermore, 
it remains to be clarified whether this substance 
merely acts as a specific competing reactant for PHA. 
This conception is supported by the observation that 
fraction I aIso inhibits the a~utination of cells by 
PHA. On the other hand, Teasdale et al. [20] 
have found that their crude hCG (3700 IU/mg) also 
inhibits lymphocyte stimulation in the mixed 
lymphocyte culture test, indicating a change of the 
properties of the lymphocytes. 
The differences between the results reported in the 
literature [g-10] can possibly be explained by hCG 
preparations of different purity. The crude hCG which 
was used in our laboratory shows a similar inhibitory 
activity to that reported by Adcock et al. [lo]. The 
hCG preparation used by Contractor et al. [9] has a 
higher inhibitory activity, but a lower biological activity. 
On the basis of the results presented in literature 
and in this paper, it is not at all clear, whether hCG is 
involved in a mechanism which prevents a rejection of 
the foetus. 
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